Greg Dillon

Greg Dillon

Company: Biogen

Job title: Senior Scientist

Seminars:

Live Q&A Session with Your Expert Speakers 12:50 pm

Read more

day: Day Two

Therapeutic Strategies for Angelman syndrome 11:50 am

Unique genetic mechanism underlying Angelman Syndrome informs multiple therapeutic approaches Learnings from ASOs are being incorporated into next-generation gene editing approaches Key considerations for success with gene therapy and gene editing approachesRead more

day: Day Two

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.